XenoPort Inc (XNPT)

7.07
0.05 0.71
Prev Close 7.02
Open 7.04
Day Low/High 7.02 / 7.07
52 Wk Low/High 3.35 / 7.86
Volume 2.62M
Avg Volume 1.64M
Exchange
Shares Outstanding 63.53M
Market Cap 449.13M
EPS -1.30
Div & Yield N.A. (N.A)

XenoPort Announces New Employment Inducement Award

First graph, second sentence of release (dated September 3, 2010) should read: The employee, Kristine Dulay, was granted restricted stock units representing an aggregate of 750 shares of XenoPort's common stock (sted ...

XenoPort Announces Changes To Executive Team

XenoPort, Inc. (Nasdaq:XNPT) announced today that William J.

XenoPort Reports Second Quarter Financial Results

XenoPort Reports Second Quarter Financial Results

XenoPort, Inc. (Nasdaq:XNPT) announced today financial results for the second quarter and six months ended June 30, 2010.

The Briscoe Law Firm, PLLC And Cash Powers Taylor, LLP Announce The Investigation Of Possible Breaches Of Fiduciary Duties By The Officers And Directors Of XenoPort, Inc.

The Briscoe Law Firm, PLLC And Cash Powers Taylor, LLP Announce The Investigation Of Possible Breaches Of Fiduciary Duties By The Officers And Directors Of XenoPort, Inc.

The Briscoe Law Firm, PLLC, founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the law firm of Cash Powers Taylor, LLP are investigating...

Goldfarb Branham Pursuing Shareholder Claims Against XenoPort

Goldfarb Branham LLP is investigating shareholder claims against XenoPort, Inc.

Kendall Law Group Begins Investigation On Behalf Of XenoPort, Inc. Shareholders

Kendall Law Group announces that a class action law suit has been filed today in the United States District Court for the Northern District of California on behalf of investors that purchased XenoPort, Inc.

Law Offices Of Howard G. Smith Announces Class Action Lawsuit Against XenoPort, Inc.

Law Offices Of Howard G. Smith Announces Class Action Lawsuit Against XenoPort, Inc.

Law Offices of Howard G. Smith announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased the common stock of XenoPort, Inc.

Bernstein Liebhard LLP Announces Filing Of Action On Behalf Of Investors In XenoPort, Inc.

Bernstein Liebhard LLP Announces Filing Of Action On Behalf Of Investors In XenoPort, Inc.

Bernstein Liebhard LLP today announced that a class action has been filed in the United States District Court for the Northern District of California on behalf of purchasers (the “Class”) of XenoPort, Inc.

Robbins Umeda LLP Announces Investigation Of XenoPort, Inc.

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by certain officers and directors at XenoPort, Inc.

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against XenoPort, Inc.

Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) ( http://www.

XenoPort To Release Second Quarter Financial Results On August 5, 2010

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its second quarter financial results on August 5, 2010 at approximately 4:30 p.

XenoPort To Present At The Wedbush Life Sciences Conference

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Wedbush Life Sciences Best Ideas Conference 2010.

XenoPort Announces Presentation Of Preclinical Data For Acamprosate Prodrug At Fragile X Syndrome Conference

XenoPort, Inc. (Nasdaq:XNPT) announced today that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved ...

GlaxoSmithKline And XenoPort Report Top-Line Phase 2b Results For GSK1838262/XP13512 As A Prophylactic Treatment For Migraine Headache

GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a ...

XenoPort Announces New Employment Inducement Awards

XenoPort, Inc. reported today that equity awards were made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan.

XenoPort To Present At The Goldman Sachs Healthcare Conference 2010

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Goldman Sachs Healthcare Conference 2010.

XenoPort Announces Presentations Of Data For Arbaclofen Placarbil And XP13512 At The Associated Professional Sleep Society Meeting

XenoPort announced today that data from clinical trials of its product candidates arbaclofen placarbil and XP13512 (gabapentin enacarbil) will be presented at the Associated Professional Sleep Society meeting in San...

XenoPort To Present At The 2010 Citi Health Care Conference

XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2010 Citi Investment Research Global Health Care Conference.

XenoPort Reports First Quarter Financial Results

XenoPort, Inc. (Nasdaq:XNPT) announced today its financial results for the first quarter ended March 31, 2010.

XenoPort Announces Presentations Of New Data For Arbaclofen Placarbil At Digestive Disease Week Meeting

XenoPort, Inc. (Nasdaq:XNPT) announced today that new data from clinical trials of its product candidate arbaclofen placarbil will be presented at the Digestive Disease Week meeting in New Orleans, LA.

Kendall Law Group Begins Investigation On Behalf Of XenoPort, Inc. Shareholders

Kendall Law Group announced today that it is investigating XenoPort, Inc.

Holzer Holzer & Fistel, LLC Is Investigating Potential Violations Of Federal Securities Laws By Xenoport, Inc.

Holzer Holzer & Fistel, LLC is investigating potential violations of the federal securities laws by XenoPort, Inc.

XenoPort To Release First Quarter Financial Results On May 6, 2010

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will release its first quarter financial results on May 6, 2010 at approximately 4:30 p.

XenoPort To Present At The Deutsche Bank 35th Annual Health Care Conference

XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 35 th Annual Deutsche Bank Health Care Conference.

EPO Rules European Patent For XP13512 Is Valid

XenoPort, Inc. (Nasdaq:XNPT) announced today that the European Patent Office (EPO) Opposition Division ruled that the European patent for the composition of matter of XP13512 (European Patent No.

XenoPort Announces Presentations Of New Data For Arbaclofen Placarbil And XP13512 At American Academy Of Neurology Meeting

XenoPort announced today that new data from clinical trials of its product candidates arbaclofen placarbil and XP13512 (gabapentin enacarbil) will be presented at the 62 nd Annual American Academy of Neurology meeting...

XenoPort Restructures To Focus On Key Programs

XenoPort, Inc. (Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%.

Biotech Stock Mailbag: Rexahn Pharma

In a bonus edition of Mailbag, our biotech columnist answers readers' questions about healthcare stocks and the FDA.

Early Volume Plays: Brocade, Xenoport

Early Volume Plays: Brocade, Xenoport

Several stocks trading near $10 were poised to move on above-average volume during Tuesday's regular session.

Campbell Soup: Analysts' Upgrades, Downgrades

Campbell Soup: Analysts' Upgrades, Downgrades

Campbell Soup downgraded at Deutsche Bank to Hold from Buy; target, estimates lowered at Goldman.